Takethesis
4 known investors
Clarity is a nootropic supplement from Thesis formulated with ingredients such as CDP Choline, Lion's Mane, Panax Ginseng, and caffeine to support focus, mental clarity, and neuroplasticity. It is sold direct-to-consumer for people seeking improved cognitive performance.
Also known as Take Thesis · Thesis
Investors · 4
Company profile
researched Aug 2026Thesis (operating at takethesis.com) develops and sells nootropic supplement formulas intended to support cognitive function. The company organizes its catalog around distinct outcome-based formulas: Clarity (concentration and focus), Motivation (brain energy and awareness), Stress Reset (calm and resilience), and Neuroprotection (memory and long-term brain health). Each formula is offered on a subscription basis with pricing starting at $59 per month.
The company's stated approach centers on neuroplasticity — the premise that appropriately stimulated brains generate new neurons and strengthen synaptic connections — and on targeting neurotransmitters and hormones associated with focus, learning, motivation, memory, stress resilience and long-term brain health. Thesis describes its formulation process as data-driven, relying on iterative testing, and reports nine years of research, more than 127 ingredients tested and more than 30 beta tests.
Business model
Direct-to-consumer sale of nootropic supplement formulas via the company's website, structured as monthly subscriptions starting at $59 per formula, with an introductory 50% discount on the first month.
Recurring subscription revenue from monthly supplement shipments, with formula prices starting at $59 per month.
Traction
The company's site displays aggregate customer ratings of 4.6-4.7 out of 5 across its formulas, with 3,321 reviews for Clarity, 1,922 for Motivation, 920 for Neuroprotection and 634 for Stress Reset.
▸Full profile — market position, technology, go-to-market
Market position
Positions itself on personalization to the individual (matching customers to a specific formula) and on iterative, test-driven formulation rather than a single general-purpose product.
Technology
Nootropic formulations built around ingredients selected to act on neurotransmitters and hormones linked to focus, learning, motivation, memory and stress resilience, developed through iterative testing cycles; the company reports 127+ ingredients tested across 30+ beta tests.
Go-to-market
Online direct-to-consumer channel with an onboarding flow that matches customers to a recommended formula ("Find Your Formula"), supported by promotional first-month discounting and published customer reviews and testimonials.
Consumers seeking to improve focus and productivity, increase energy and motivation, manage stress, or support memory and long-term brain health.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 1
primary sources listed
- Takethesistakethesis.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Takethesis do?
- Thesis sells subscription nootropic supplement formulas targeting focus, energy, stress resilience, memory and brain health.
- Who are Takethesis's investors?
- Takethesis's investors include Evolution VC Partners, REDO Ventures, ECP Growth, Trust Ventures.